Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Changes in the Receptor-Binding Properties of H3N2 Viruses during Long-Term Circulation in Humans.

Gambaryan AS, Balish A, Klimov AI, Tuzikov AB, Chinarev AA, Pazynina GV, Bovin NV.

Biochemistry (Mosc). 2019 Oct;84(10):1177-1185. doi: 10.1134/S0006297919100067.

PMID:
31694513
2.

Highly sensitive detection of influenza virus with SERS aptasensor.

Kukushkin VI, Ivanov NM, Novoseltseva AA, Gambaryan AS, Yaminsky IV, Kopylov AM, Zavyalova EG.

PLoS One. 2019 Apr 25;14(4):e0216247. doi: 10.1371/journal.pone.0216247. eCollection 2019.

3.

[Three Mutations in the Stalk Region of Hemagglutinin Affect the pH of Fusion and Pathogenicity of H5N1 Influenza Virus].

Lomakina NF, Sadykova GK, Timofeeva TA, Rudneva IA, Boravleva EY, Ivanov PA, Prilipov AG, Gambaryan AS.

Mol Biol (Mosk). 2018 Nov-Dec;52(6):1029-1037. doi: 10.1134/S0026898418060125. Russian.

4.

[Mutations in Hemagglutinin and Polymerase Alter the Virulence of Pandemic A(H1N1) Influenza Virus].

Gambaryan AS, Lomakina NF, Boravleva EY, Mochalova LV, Sadykova GK, Prilipov AG, Matrosovich TY, Matrosovich MN.

Mol Biol (Mosk). 2018 Jul-Aug;52(4):644-658. doi: 10.1134/S0026898418040055. Russian.

5.

Receptor-binding properties of influenza viruses isolated from gulls.

Gambaryan AS, Matrosovich TY, Boravleva EY, Lomakina NF, Yamnikova SS, Tuzikov AB, Pazynina GV, Bovin NV, Fouchier RAM, Klenk HD, Matrosovich MN.

Virology. 2018 Sep;522:37-45. doi: 10.1016/j.virol.2018.07.004. Epub 2018 Jul 12.

6.

Immunization of Domestic Ducks with Live Nonpathogenic H5N3 Influenza Virus Prevents Shedding and Transmission of Highly Pathogenic H5N1 Virus to Chickens.

Gambaryan A, Gordeychuk I, Boravleva E, Lomakina N, Kropotkina E, Lunitsin A, Klenk HD, Matrosovich M.

Viruses. 2018 Mar 31;10(4). pii: E164. doi: 10.3390/v10040164.

7.

[Changes in the phenotypic properties of highly pathogenic influenza A virus of H5N1 subtype induced by N186I and N186T point mutations in hemagglutinin].

Timofeeva TA, Sadykova GK, Rudneva IA, Boravleva EY, Gambaryan AS, Lomakina NF, Mochalova LV, Bovin NV, Usachev EV, Prilipov AG.

Mol Biol (Mosk). 2016 Sep-Oct;50(5):855-862. Russian.

8.

Immunization with live nonpathogenic H5N3 duck influenza virus protects chickens against highly pathogenic H5N1 virus.

Gambaryan AS, Boravleva EY, Lomakina NF, Kropotkina EA, Gordeychuk IV, Chvala IA, Drygin VV, Klenk HD, Matrosovich MN.

Acta Virol. 2016;60(3):316-27.

PMID:
27640442
9.

[Testing of apathogenic influenza virus H5N3 as a poultry live vaccine].

Boravleva EY, Chvala IA, Lomakina NF, Repin PI, Mudrak NS, Rudenko LG, Gambaryan AS, Drygin VV.

Vopr Virusol. 2015;60(4):44-9. Russian.

PMID:
26665435
10.

What adaptive changes in hemagglutinin and neuraminidase are necessary for emergence of pandemic influenza virus from its avian precursor?

Gambaryan AS, Matrosovich MN.

Biochemistry (Mosc). 2015 Jul;80(7):872-80. doi: 10.1134/S000629791507007X. Review.

11.

Labeling of influenza viruses with synthetic fluorescent and biotin-labeled lipids.

Ilyushina NA, Chernyy ES, Korchagina EY, Gambaryan AS, Henry SM, Bovin NV.

Virol Sin. 2014 Aug;29(4):199-210. doi: 10.1007/s12250-014-3475-1. Epub 2014 Jul 31.

PMID:
25160755
12.

Biantennary oligoglycines and glyco-oligoglycines self-associating in aqueous medium.

Tsygankova SV, Chinarev AA, Tuzikov AB, Severin N, Kalachev AA, Rabe JP, Gambaryan AS, Bovin NV.

Beilstein J Org Chem. 2014 Jun 17;10:1372-82. doi: 10.3762/bjoc.10.140. eCollection 2014.

13.

Solid-phase assays of receptor-binding specificity.

Matrosovich MN, Gambaryan AS.

Methods Mol Biol. 2012;865:71-94. doi: 10.1007/978-1-61779-621-0_5.

PMID:
22528154
14.

Receptor-binding profiles of H7 subtype influenza viruses in different host species.

Gambaryan AS, Matrosovich TY, Philipp J, Munster VJ, Fouchier RA, Cattoli G, Capua I, Krauss SL, Webster RG, Banks J, Bovin NV, Klenk HD, Matrosovich MN.

J Virol. 2012 Apr;86(8):4370-9. doi: 10.1128/JVI.06959-11. Epub 2012 Feb 15.

15.

Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).

Gambaryan AS, Lomakina NF, Boravleva EY, Kropotkina EA, Mashin VV, Krasilnikov IV, Klimov AI, Rudenko LG.

Influenza Other Respir Viruses. 2012 May;6(3):188-95. doi: 10.1111/j.1750-2659.2011.00291.x. Epub 2011 Sep 23.

16.

Molecular adaptation of an H7N3 wild duck influenza virus following experimental multiple passages in quail and turkey.

Giannecchini S, Clausi V, Di Trani L, Falcone E, Terregino C, Toffan A, Cilloni F, Matrosovich M, Gambaryan AS, Bovin NV, Delogu M, Capua I, Donatelli I, Azzi A.

Virology. 2010 Dec 20;408(2):167-73. doi: 10.1016/j.virol.2010.09.011. Epub 2010 Oct 14.

17.

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).

Rudenko L, Desheva J, Korovkin S, Mironov A, Rekstin A, Grigorieva E, Donina S, Gambaryan A, Katlinsky A.

Influenza Other Respir Viruses. 2008 Nov;2(6):203-9. doi: 10.1111/j.1750-2659.2008.00064.x.

18.

6-sulfo sialyl Lewis X is the common receptor determinant recognized by H5, H6, H7 and H9 influenza viruses of terrestrial poultry.

Gambaryan AS, Tuzikov AB, Pazynina GV, Desheva JA, Bovin NV, Matrosovich MN, Klimov AI.

Virol J. 2008 Jul 24;5:85. doi: 10.1186/1743-422X-5-85.

19.

Inhibition of influenza M2-induced cell death alleviates its negative contribution to vaccination efficiency.

Ilyinskii PO, Gambaryan AS, Meriin AB, Gabai V, Kartashov A, Thoidis G, Shneider AM.

PLoS One. 2008 Jan 16;3(1):e1417. doi: 10.1371/journal.pone.0001417.

20.

Oligosaccharide specificity of influenza H1N1 virus neuraminidases.

Mochalova L, Kurova V, Shtyrya Y, Korchagina E, Gambaryan A, Belyanchikov I, Bovin N.

Arch Virol. 2007;152(11):2047-57. Epub 2007 Aug 6.

PMID:
17680329
21.

Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants.

Rudneva IA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, Varich NL, Ilyushina NA, Gambaryan AS, Krylov PS, Kaverin NV.

Arch Virol. 2007;152(6):1139-45. Epub 2007 Feb 9.

PMID:
17294090
22.

Evolution of the receptor binding phenotype of influenza A (H5) viruses.

Gambaryan A, Tuzikov A, Pazynina G, Bovin N, Balish A, Klimov A.

Virology. 2006 Jan 20;344(2):432-8. Epub 2005 Oct 13.

23.

Polymer-bound 6' sialyl-N-acetyllactosamine protects mice infected by influenza virus.

Gambaryan AS, Boravleva EY, Matrosovich TY, Matrosovich MN, Klenk HD, Moiseeva EV, Tuzikov AB, Chinarev AA, Pazynina GV, Bovin NV.

Antiviral Res. 2005 Dec;68(3):116-23. Epub 2005 Sep 9.

PMID:
16214231
24.

Receptor-binding properties of swine influenza viruses isolated and propagated in MDCK cells.

Gambaryan AS, Karasin AI, Tuzikov AB, Chinarev AA, Pazynina GV, Bovin NV, Matrosovich MN, Olsen CW, Klimov AI.

Virus Res. 2005 Dec;114(1-2):15-22. Epub 2005 Jul 5.

PMID:
15996787
25.

Fluorescent assay for studying the substrate specificity of neuraminidase.

Mochalova LV, Korchagina EY, Kurova VS, Shtyria JA, Gambaryan AS, Bovin NV.

Anal Biochem. 2005 Jun 1;341(1):190-3. No abstract available.

PMID:
15866544
26.

Receptor specificity of influenza viruses from birds and mammals: new data on involvement of the inner fragments of the carbohydrate chain.

Gambaryan A, Yamnikova S, Lvov D, Tuzikov A, Chinarev A, Pazynina G, Webster R, Matrosovich M, Bovin N.

Virology. 2005 Apr 10;334(2):276-83.

27.

Multimeric glycotherapeutics: new paradigm.

Bovin NV, Tuzikov AB, Chinarev AA, Gambaryan AS.

Glycoconj J. 2004;21(8-9):471-8. Review.

PMID:
15750788
28.
29.

H5N1 chicken influenza viruses display a high binding affinity for Neu5Acalpha2-3Galbeta1-4(6-HSO3)GlcNAc-containing receptors.

Gambaryan AS, Tuzikov AB, Pazynina GV, Webster RG, Matrosovich MN, Bovin NV.

Virology. 2004 Sep 1;326(2):310-6.

30.

Receptor specificity of H5 influenza virus escape mutants.

Ilyushina NA, Rudneva IA, Gambaryan AS, Tuzikov AB, Bovin NV.

Virus Res. 2004 Mar 15;100(2):237-41.

PMID:
15019242
31.

Differences between HA receptor-binding sites of avian influenza viruses isolated from Laridae and Anatidae.

Yamnikova SS, Gambaryan AS, Tuzikov AB, Bovin NV, Matrosovich MN, Fedyakina IT, Grinev AA, Blinov VM, Lvov DK, Suarez DL, Swayne DE.

Avian Dis. 2003;47(3 Suppl):1164-8.

PMID:
14575135
32.

Differences between influenza virus receptors on target cells of duck and chicken and receptor specificity of the 1997 H5N1 chicken and human influenza viruses from Hong Kong.

Gambaryan AS, Tuzikov AB, Bovin NV, Yamnikova SS, Lvov DK, Webster RG, Matrosovich MN.

Avian Dis. 2003;47(3 Suppl):1154-60.

PMID:
14575133
33.

Receptor-binding properties of modern human influenza viruses primarily isolated in Vero and MDCK cells and chicken embryonated eggs.

Mochalova L, Gambaryan A, Romanova J, Tuzikov A, Chinarev A, Katinger D, Katinger H, Egorov A, Bovin N.

Virology. 2003 Sep 1;313(2):473-80.

34.

Polyglycine II nanosheets: supramolecular antivirals?

Tuzikov AB, Chinarev AA, Gambaryan AS, Oleinikov VA, Klinov DV, Matsko NB, Kadykov VA, Ermishov MA, Demin IV, Demin VV, Rye PD, Bovin NV.

Chembiochem. 2003 Mar 3;4(2-3):147-54.

PMID:
12616627
35.

Differences between influenza virus receptors on target cells of duck and chicken.

Gambaryan A, Webster R, Matrosovich M.

Arch Virol. 2002 Jun;147(6):1197-208.

PMID:
12111429
36.

Polymeric inhibitor of influenza virus attachment protects mice from experimental influenza infection.

Gambaryan AS, Tuzikov AB, Chinarev AA, Juneja LR, Bovin NV, Matrosovich MN.

Antiviral Res. 2002 Jul;55(1):201-5.

PMID:
12076764
37.

Amino acid changes in the hemagglutinin and matrix proteins of influenza a (H2) viruses adapted to mice.

Govorkova EA, Gambaryan AS, Claas EC, Smirnov YA.

Acta Virol. 2000 Oct;44(5):241-8.

PMID:
11252668
38.

Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals.

Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, Castrucci MR, Donatelli I, Kawaoka Y.

J Virol. 2000 Sep;74(18):8502-12.

39.

Intergenic HA-NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes.

Kaverin NV, Matrosovich MN, Gambaryan AS, Rudneva IA, Shilov AA, Varich NL, Makarova NV, Kropotkina EA, Sinitsin BV.

Virus Res. 2000 Feb;66(2):123-9.

PMID:
10725545
40.

Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses.

Gambaryan AS, Robertson JS, Matrosovich MN.

Virology. 1999 Jun 5;258(2):232-9.

42.

Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs.

Gambaryan AS, Marinina VP, Tuzikov AB, Bovin NV, Rudneva IA, Sinitsyn BV, Shilov AA, Matrosovich MN.

Virology. 1998 Aug 1;247(2):170-7.

43.

Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match.

Kaverin NV, Gambaryan AS, Bovin NV, Rudneva IA, Shilov AA, Khodova OM, Varich NL, Sinitsin BV, Makarova NV, Kropotkina EA.

Virology. 1998 May 10;244(2):315-21.

44.

Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.

Matrosovich MN, Gambaryan AS, Teneberg S, Piskarev VE, Yamnikova SS, Lvov DK, Robertson JS, Karlsson KA.

Virology. 1997 Jun 23;233(1):224-34.

46.

Monovalent and polymeric 5N-thioacetamido sialosides as tightly-bound receptor analogs of influenza viruses.

Tuzikov AB, Byramova NE, Bovin NV, Gambaryan AS, Matrosovich MN.

Antiviral Res. 1997 Jan;33(2):129-34.

PMID:
9021054
47.

Human influenza virus recognition of sialyloligosaccharides.

Gambaryan AS, Piskarev VE, Yamskov IA, Sakharov AM, Tuzikov AB, Bovin NV, Nifant'ev NE, Matrosovich MN.

FEBS Lett. 1995 Jun 5;366(1):57-60.

48.

Synthetic polymeric inhibitors of influenza virus receptor-binding activity suppress virus replication.

Mochalova LV, Tuzikov AB, Marinina VP, Gambaryan AS, Byramova NE, Bovin NV, Matrosovich MN.

Antiviral Res. 1994 Apr;23(3-4):179-90.

PMID:
7519002
49.

Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides.

Matrosovich MN, Gambaryan AS, Tuzikov AB, Byramova NE, Mochalova LV, Golbraikh AA, Shenderovich MD, Finne J, Bovin NV.

Virology. 1993 Sep;196(1):111-21.

PMID:
8356788
50.

A solid-phase enzyme-linked assay for influenza virus receptor-binding activity.

Gambaryan AS, Matrosovich MN.

J Virol Methods. 1992 Sep;39(1-2):111-23.

PMID:
1430058

Supplemental Content

Loading ...
Support Center